Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluomizin (dequalinium chloride 10 mg) for aerobic bacterial vaginal infections vs placebo
2006-004399-11Phase 3Completed
- Sponsor
- Medinova AG
- Start
- Sep 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Aerobic Vaginitis (AV) and vaginitis comparing Fluomizin with Placebo (2 arms). Primary endpoint: Clinical cure at C2. Started Sep 2006; status: completed.
02
Drugs
dequalinium
03
Conditions
Aerobic Vaginitis (AV)vaginitis
Beyond the preview
Go deeper on 2006-004399-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004399-11.